Blood Culture Test Market Outlook 2022-2027 | Industry Opportunity & Growth Analysisby Zayn Mathew Market Research Reports
According to a new report by IMARC Group, the global blood culture test market grew at a CAGR of around 9% during 2022-2027. Looking forward, the market is expected to continue its moderate growth during the next five years.
A blood culture test is conducted to diagnose bacterial, fungal, and mycobacterial infections in the blood. It identifies various microorganisms in the blood sample and prevents the development of sepsis. The culture test helps in determining typical pathogens in the blood and possible ways to treat them. It utilizes blood culture media, assay kits, reagents, automated blood culture systems, and supporting laboratory equipment.
The sudden outbreak of COVID-19 has predominantly catalyzed the demand for blood culture tests to combat disease transmission. Several medical laboratories, diagnostic centers, and other healthcare facilities are widely adopting these tests to identify the presence of antibodies in the blood and isolate the infected individuals. The rising geriatric population, along with the growing consumer health concerns towards the high prevalence of infectious diseases, is further bolstering the market growth. The increasing healthcare expenditures, along with the growing number of R&D activities in the medical sector, are also proliferating the growth of the blood culture test market.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Insights on Market Segmentation:
Market Segmentation by Testing Method:
Market Segmentation by Product:
- Software and Services
Breakup by Technology:
- Culture-based Technology
- Molecular Technology
- Proteomic Technology
Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/blood-culture-test-market
Market Segmentation by Application:
- Bacterial Infection
- Fungal Infection
- Mycobacterial Infection
- Breakup by End-User:
- Hospital Laboratories
- Reference Laboratories
- Research Laboratories
Market Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Beckman Coulter (Danaher Corporation)BD (Becton, Dickinson and Company), Biomérieux SA, Bruker Corporation, Cepheid Inc. (Danaher Corporation), Luminex Corporation, Merck Group, Siemens Healthineers AG, Roche Diagnostics, T2 Biosystems, Thermo Fisher Scientific Inc., etc.
Idiopathic Pulmonary Fibrosis Treatment Market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St
Sheridan, WY 82801
Follow us on twitter: @imarcglobal
Created on Jun 10th 2020 08:15. Viewed 264 times.